 | • レポートコード：D0804-16609 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、108ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、敗血症バイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。敗血症バイオマーカーの種類別市場規模（血液バイオマーカー、尿バイオマーカー）、用途別市場規模（診断、創薬、個別化医療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific、Abbott、QIAGEN、Merck、Siemens Healthcare、Bio-Rad Laboratories、HiMedia Laboratories、Danaher Corporation、Roche、GenMark Diagnostics、Immunexpress、Abionic、T2 Biosystems ・地域別グローバル市場分析 2015年-2020年 ・敗血症バイオマーカーの北米市場（アメリカ、カナダ、メキシコ） ・敗血症バイオマーカーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・敗血症バイオマーカーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・敗血症バイオマーカーの南米市場（ブラジル、アルゼンチン） ・敗血症バイオマーカーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：血液バイオマーカー、尿バイオマーカー ・用途別分析：診断、創薬、個別化医療、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Sepsis Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Sepsis Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sepsis Biomarkers market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sepsis Biomarkers market has been segmented into:
Blood Biomarkers
Urine Biomarkers
By Application, Sepsis Biomarkers has been segmented into:
Diagnostics
Drug Discovery
Personalized Medicine
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sepsis Biomarkers market presented in the report. This section sheds light on the sales growth of different regional and country-level Sepsis Biomarkers markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sepsis Biomarkers market.
The report offers in-depth assessment of the growth and other aspects of the Sepsis Biomarkers market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Sepsis Biomarkers Market Share Analysis
Sepsis Biomarkers competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sepsis Biomarkers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sepsis Biomarkers sales, revenue and market share for each player covered in this report.
The major players covered in Sepsis Biomarkers are:
Thermo Fisher Scientific
Abbott
QIAGEN
Merck
Siemens Healthcare
Bio-Rad Laboratories
HiMedia Laboratories
Danaher Corporation
Roche
GenMark Diagnostics
Immunexpress
Abionic
T2 Biosystems
1 Sepsis Biomarkers Market Overview
1.1 Product Overview and Scope of Sepsis Biomarkers
1.2 Classification of Sepsis Biomarkers by Type
1.2.1 Global Sepsis Biomarkers Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Sepsis Biomarkers Revenue Market Share by Type in 2019
1.2.3 Blood Biomarkers
1.2.4 Urine Biomarkers
1.3 Global Sepsis Biomarkers Market by Application
1.3.1 Overview: Global Sepsis Biomarkers Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Global Sepsis Biomarkers Market by Regions
1.4.1 Global Sepsis Biomarkers Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Sepsis Biomarkers (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Sepsis Biomarkers Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Sepsis Biomarkers Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sepsis Biomarkers Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Sepsis Biomarkers Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sepsis Biomarkers Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Abbott SWOT Analysis
2.2.4 Abbott Product and Services
2.2.5 Abbott Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.3 QIAGEN
2.3.1 QIAGEN Details
2.3.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 QIAGEN SWOT Analysis
2.3.4 QIAGEN Product and Services
2.3.5 QIAGEN Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.5 Siemens Healthcare
2.5.1 Siemens Healthcare Details
2.5.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Siemens Healthcare SWOT Analysis
2.5.4 Siemens Healthcare Product and Services
2.5.5 Siemens Healthcare Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bio-Rad Laboratories SWOT Analysis
2.6.4 Bio-Rad Laboratories Product and Services
2.6.5 Bio-Rad Laboratories Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.7 HiMedia Laboratories
2.7.1 HiMedia Laboratories Details
2.7.2 HiMedia Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 HiMedia Laboratories SWOT Analysis
2.7.4 HiMedia Laboratories Product and Services
2.7.5 HiMedia Laboratories Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.8 Danaher Corporation
2.8.1 Danaher Corporation Details
2.8.2 Danaher Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Danaher Corporation SWOT Analysis
2.8.4 Danaher Corporation Product and Services
2.8.5 Danaher Corporation Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.10 GenMark Diagnostics
2.10.1 GenMark Diagnostics Details
2.10.2 GenMark Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GenMark Diagnostics SWOT Analysis
2.10.4 GenMark Diagnostics Product and Services
2.10.5 GenMark Diagnostics Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.11 Immunexpress
2.11.1 Immunexpress Details
2.11.2 Immunexpress Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Immunexpress SWOT Analysis
2.11.4 Immunexpress Product and Services
2.11.5 Immunexpress Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.12 Abionic
2.12.1 Abionic Details
2.12.2 Abionic Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Abionic SWOT Analysis
2.12.4 Abionic Product and Services
2.12.5 Abionic Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.13 T2 Biosystems
2.13.1 T2 Biosystems Details
2.13.2 T2 Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 T2 Biosystems SWOT Analysis
2.13.4 T2 Biosystems Product and Services
2.13.5 T2 Biosystems Sepsis Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sepsis Biomarkers Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Sepsis Biomarkers Players Market Share
3.2.2 Top 10 Sepsis Biomarkers Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Sepsis Biomarkers Revenue and Market Share by Regions
4.2 North America Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
4.3 Europe Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
4.5 South America Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
5 North America Sepsis Biomarkers Revenue by Countries
5.1 North America Sepsis Biomarkers Revenue by Countries (2015-2020)
5.2 USA Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
5.3 Canada Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
5.4 Mexico Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
6 Europe Sepsis Biomarkers Revenue by Countries
6.1 Europe Sepsis Biomarkers Revenue by Countries (2015-2020)
6.2 Germany Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
6.3 UK Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
6.4 France Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
6.5 Russia Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
6.6 Italy Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Sepsis Biomarkers Revenue by Countries
7.1 Asia-Pacific Sepsis Biomarkers Revenue by Countries (2015-2020)
7.2 China Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
7.3 Japan Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
7.4 Korea Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
7.5 India Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
8 South America Sepsis Biomarkers Revenue by Countries
8.1 South America Sepsis Biomarkers Revenue by Countries (2015-2020)
8.2 Brazil Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
8.3 Argentina Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Sepsis Biomarkers by Countries
9.1 Middle East & Africa Sepsis Biomarkers Revenue by Countries (2015-2020)
9.2 Saudi Arabia Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
9.3 UAE Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
9.4 Egypt Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
9.5 South Africa Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Sepsis Biomarkers Revenue and Market Share by Type (2015-2020)
10.2 Global Sepsis Biomarkers Market Forecast by Type (2019-2024)
10.3 Blood Biomarkers Revenue Growth Rate (2015-2025)
10.4 Urine Biomarkers Revenue Growth Rate (2015-2025)
11 Global Sepsis Biomarkers Market Segment by Application
11.1 Global Sepsis Biomarkers Revenue Market Share by Application (2015-2020)
11.2 Sepsis Biomarkers Market Forecast by Application (2019-2024)
11.3 Diagnostics Revenue Growth (2015-2020)
11.4 Drug Discovery Revenue Growth (2015-2020)
11.5 Personalized Medicine Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Sepsis Biomarkers Market Size Forecast (2021-2025)
12.1 Global Sepsis Biomarkers Market Size Forecast (2021-2025)
12.2 Global Sepsis Biomarkers Market Forecast by Regions (2021-2025)
12.3 North America Sepsis Biomarkers Revenue Market Forecast (2021-2025)
12.4 Europe Sepsis Biomarkers Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Sepsis Biomarkers Revenue Market Forecast (2021-2025)
12.6 South America Sepsis Biomarkers Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Sepsis Biomarkers Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Sepsis Biomarkers Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sepsis Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sepsis Biomarkers Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Sepsis Biomarkers Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 6. Thermo Fisher Scientific Sepsis Biomarkers Major Business
Table 7. Thermo Fisher Scientific Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher Scientific SWOT Analysis
Table 9. Thermo Fisher Scientific Sepsis Biomarkers Product and Solutions
Table 10. Thermo Fisher Scientific Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Abbott Corporate Information, Location and Competitors
Table 12. Abbott Sepsis Biomarkers Major Business
Table 13. Abbott Sepsis Biomarkers Total Revenue (USD Million) (2018-2019)
Table 14. Abbott SWOT Analysis
Table 15. Abbott Sepsis Biomarkers Product and Solutions
Table 16. Abbott Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. QIAGEN Corporate Information, Location and Competitors
Table 18. QIAGEN Sepsis Biomarkers Major Business
Table 19. QIAGEN Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 20. QIAGEN SWOT Analysis
Table 21. QIAGEN Sepsis Biomarkers Product and Solutions
Table 22. QIAGEN Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Sepsis Biomarkers Major Business
Table 25. Merck Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Sepsis Biomarkers Product and Solutions
Table 28. Merck Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Siemens Healthcare Corporate Information, Location and Competitors
Table 30. Siemens Healthcare Sepsis Biomarkers Major Business
Table 31. Siemens Healthcare Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 32. Siemens Healthcare SWOT Analysis
Table 33. Siemens Healthcare Sepsis Biomarkers Product and Solutions
Table 34. Siemens Healthcare Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 36. Bio-Rad Laboratories Sepsis Biomarkers Major Business
Table 37. Bio-Rad Laboratories Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 38. Bio-Rad Laboratories SWOT Analysis
Table 39. Bio-Rad Laboratories Sepsis Biomarkers Product and Solutions
Table 40. Bio-Rad Laboratories Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. HiMedia Laboratories Corporate Information, Location and Competitors
Table 42. HiMedia Laboratories Sepsis Biomarkers Major Business
Table 43. HiMedia Laboratories Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 44. HiMedia Laboratories SWOT Analysis
Table 45. HiMedia Laboratories Sepsis Biomarkers Product and Solutions
Table 46. HiMedia Laboratories Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Danaher Corporation Corporate Information, Location and Competitors
Table 48. Danaher Corporation Sepsis Biomarkers Major Business
Table 49. Danaher Corporation Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 50. Danaher Corporation SWOT Analysis
Table 51. Danaher Corporation Sepsis Biomarkers Product and Solutions
Table 52. Danaher Corporation Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Sepsis Biomarkers Major Business
Table 55. Roche Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Sepsis Biomarkers Product and Solutions
Table 58. Roche Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. GenMark Diagnostics Corporate Information, Location and Competitors
Table 60. GenMark Diagnostics Sepsis Biomarkers Major Business
Table 61. GenMark Diagnostics Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 62. GenMark Diagnostics SWOT Analysis
Table 63. GenMark Diagnostics Sepsis Biomarkers Product and Solutions
Table 64. GenMark Diagnostics Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Immunexpress Corporate Information, Location and Competitors
Table 66. Immunexpress Sepsis Biomarkers Major Business
Table 67. Immunexpress Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 68. Immunexpress SWOT Analysis
Table 69. Immunexpress Sepsis Biomarkers Product and Solutions
Table 70. Immunexpress Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Abionic Corporate Information, Location and Competitors
Table 72. Abionic Sepsis Biomarkers Major Business
Table 73. Abionic Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 74. Abionic SWOT Analysis
Table 75. Abionic Sepsis Biomarkers Product and Solutions
Table 76. Abionic Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. T2 Biosystems Corporate Information, Location and Competitors
Table 78. T2 Biosystems Sepsis Biomarkers Major Business
Table 79. T2 Biosystems Sepsis Biomarkers Total Revenue (USD Million) (2017-2018)
Table 80. T2 Biosystems SWOT Analysis
Table 81. T2 Biosystems Sepsis Biomarkers Product and Solutions
Table 82. T2 Biosystems Sepsis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Sepsis Biomarkers Revenue (Million USD) by Players (2015-2020)
Table 84. Global Sepsis Biomarkers Revenue Share by Players (2015-2020)
Table 85. Global Sepsis Biomarkers Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Sepsis Biomarkers Revenue Market Share by Regions (2015-2020)
Table 87. North America Sepsis Biomarkers Revenue by Countries (2015-2020)
Table 88. North America Sepsis Biomarkers Revenue Market Share by Countries (2015-2020)
Table 89. Europe Sepsis Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Sepsis Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Sepsis Biomarkers Revenue by Countries (2015-2020)
Table 92. South America Sepsis Biomarkers Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Sepsis Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Sepsis Biomarkers Revenue Market Share by Countries (2015-2020)
Table 95. Global Sepsis Biomarkers Revenue (Million USD) by Type (2015-2020)
Table 96. Global Sepsis Biomarkers Revenue Share by Type (2015-2020)
Table 97. Global Sepsis Biomarkers Revenue Forecast by Type (2021-2025)
Table 98. Global Sepsis Biomarkers Revenue by Application (2015-2020)
Table 99. Global Sepsis Biomarkers Revenue Share by Application (2015-2020)
Table 100. Global Sepsis Biomarkers Revenue Forecast by Application (2021-2025)
Table 101. Global Sepsis Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Sepsis Biomarkers Picture
Figure 2. Global Sepsis Biomarkers Revenue Market Share by Type in 2019
Figure 3. Blood Biomarkers Picture
Figure 4. Urine Biomarkers Picture
Figure 5. Sepsis Biomarkers Revenue Market Share by Application in 2019
Figure 6. Diagnostics Picture
Figure 7. Drug Discovery Picture
Figure 8. Personalized Medicine Picture
Figure 9. Others Picture
Figure 10. Global Sepsis Biomarkers Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Sepsis Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Sepsis Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Sepsis Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Sepsis Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Sepsis Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Sepsis Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Sepsis Biomarkers Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Sepsis Biomarkers Revenue Market Share in 2019
Figure 19. Global Top 10 Players Sepsis Biomarkers Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Sepsis Biomarkers Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Sepsis Biomarkers Revenue Market Share by Regions (2015-2020)
Figure 23. Global Sepsis Biomarkers Revenue Market Share by Regions in 2018
Figure 24. North America Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 25. Europe Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 27. South America Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 29. North America Sepsis Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 30. North America Sepsis Biomarkers Revenue Market Share by Countries in 2019
Figure 31. USA Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 32. Canada Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 34. Europe Sepsis Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Sepsis Biomarkers Revenue Market Share by Countries in 2019
Figure 36. Germany Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 37. UK Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 38. France Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 39. Russia Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 40. Italy Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Sepsis Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Sepsis Biomarkers Revenue Market Share by Countries in 2019
Figure 43. China Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 44. Japan Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 45. Korea Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 46. India Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 48. South America Sepsis Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 49. South America Sepsis Biomarkers Revenue Market Share by Countries in 2019
Figure 50. Brazil Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Sepsis Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Sepsis Biomarkers Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 55. UAE Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Sepsis Biomarkers Revenue and Growth Rate (2015-2020)
Figure 58. Global Sepsis Biomarkers Revenue Share by Type (2015-2020)
Figure 59. Global Sepsis Biomarkers Revenue Share by Type in 2019
Figure 60. Global Sepsis Biomarkers Market Share Forecast by Type (2021-2025)
Figure 61. Global Blood Biomarkers Revenue Growth Rate (2015-2020)
Figure 62. Global Urine Biomarkers Revenue Growth Rate (2015-2020)
Figure 63. Global Sepsis Biomarkers Revenue Share by Application (2015-2020)
Figure 64. Global Sepsis Biomarkers Revenue Share by Application in 2019
Figure 65. Global Sepsis Biomarkers Market Share Forecast by Application (2021-2025)
Figure 66. Global Diagnostics Revenue Growth Rate (2015-2020)
Figure 67. Global Drug Discovery Revenue Growth Rate (2015-2020)
Figure 68. Global Personalized Medicine Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Sepsis Biomarkers Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Sepsis Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Sepsis Biomarkers Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Sepsis Biomarkers Revenue Market Forecast (2021-2025)
Figure 74. Europe Sepsis Biomarkers Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Sepsis Biomarkers Revenue Market Forecast (2021-2025)
Figure 76. South America Sepsis Biomarkers Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Sepsis Biomarkers Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
外傷性脳損傷（TBI）テストバイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Traumatic Brain Injury (TBI) Testing Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…- 脳卒中検査バイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Stroke Testing Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Stroke Testing Biom…
- 脳卒中検査バイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Stroke Testing Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Stroke Testing Biom…
- 抗生物質スチュワードシップバイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Antibiotic Stewardship Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antibiotic …
- 抗生物質耐性バイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Antibiotic Resistance Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antibiotic R…